Organisation paid for research Program year 2020 Source: CMS Open Payments

Amr - Baber Research

Neither a doctor nor a teaching hospital

Research payments

$96,412

19 payments

Through program year 2020, Amr - Baber Research is reported as receiving $96,412 in research payments, across 19 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$49,543	15
2019	Research	$46,869	4

Breakdown

Who paid Research payments · program years 2019–2020

H. Lundbeck A S $96,412 19 payments

Studies the money was for Research payments · program years 2019–2020

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Pediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD) $40,574 7 payments
Real-life Effectiveness of Vortioxetine in Depression RELIEVE $23,369 1 payment
Active Reference Fluoxetine Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder MDD $12,033 1 payment
Active Reference Fluoxetine Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder MDD $10,681 1 payment
Real-life Effectiveness of Vortioxetine in Depression (RELIEVE) $8,969 8 payments
Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder MDD From 7 to 18 Years of Age $787 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.